Litcius/Paper detail

European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism

Etienne Cavalier, Pierre Lukas, Michela Bottani, Aasne K. Aarsand, Ferruccio Ceriotti, Abdurrahman Coşkun, Jorge Díaz–Garzón, Pilar Fernández–Calle, Elena Guerra, Matteo Locatelli, Sverre Sandberg, Anna Carobene

2020Osteoporosis International47 citationsDOIOpen Access PDF

Topics & Concepts

N-terminal telopeptideType I collagenMedicineOsteocalcinTerminal (telecommunication)Internal medicineEndocrinologyVariation (astronomy)Collagen, type I, alpha 1BiochemistryBiologyAlkaline phosphataseExtracellular matrixEnzymeAstrophysicsPhysicsTelecommunicationsComputer scienceBone health and osteoporosis researchClinical Laboratory Practices and Quality ControlAdvanced Proteomics Techniques and Applications
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein—a cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism | Litcius